Results 1 to 10 of about 38,036 (299)

Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries. [PDF]

open access: yesInt J Environ Res Public Health, 2022
Patients are recognized as important players in the pharmacovigilance system. This study aims to describe and compare the characteristics of patient reporting systems, reporting forms, awareness raising-activities, and the statistics related to patient reporting in the selected countries.
Worakunphanich W   +4 more
europepmc   +4 more sources

Exploring willingness to use adverse drug reaction reporting systems: a multicentre qualitative study in China based on the technology acceptance model and task-technology fit integration approach [PDF]

open access: yesBMJ Open
Background Adverse drug reaction (ADR) reporting systems are critical for monitoring and managing drug safety. However, various factors influence the willingness to use these systems.
Xue Yang   +6 more
doaj   +3 more sources

Legislation and current developments in adverse drug reaction reporting in Mongolia: how far are we? [PDF]

open access: yesJournal of Pharmaceutical Policy and Practice, 2021
Monitoring adverse drug reactions is a vital issue to ensure drug safety and to protect the general public from medication-related harmful effects.
Zuzaan Zulzaga   +3 more
doaj   +2 more sources

Knowledge of Adverse Drug Reactions Reporting among Doctors and Nurses in a Tertiary Care Hospital: A Descriptive Cross-sectional Study

open access: yesJournal of Nepal Medical Association, 2021
Introduction: Doctors and nurses have a significant role in the detection of serious and unusual drug reactions. Effective implementation of an adverse drug reaction reporting system is required to ensure patient safety and quality care.
Rekha Shah   +2 more
doaj   +2 more sources

A novel way to overcome the challenge of under-reporting of adverse drug reactions in a tertiary care hospital: A pharmacovigilance study

open access: yesNational Journal of Physiology, Pharmacy and Pharmacology, 2022
Background: Adverse drug reactions (ADRs) constitute a major clinical problem in terms of human suffering and increased health-care costs all over the world.
Shailander Singh   +2 more
doaj   +1 more source

Assessment of knowledge, practices, and barriers to pharmacovigilance among nurses at a teaching hospital, Ghana: a cross‑sectional study

open access: yesBMC Nursing, 2022
Background Pharmacovigilance may be defined as the continuous monitoring of the reaction between a drug agent or combination of drugs a patient took and steps taken to prevent any associated risk.
Paa Kofi Tawiah Adu-Gyamfi   +6 more
doaj   +1 more source

Unknown adverse drug reactions from spontaneous reports in a hospital setting: characterization, follow-up, and contribution to the pharmacovigilance system

open access: yesFrontiers in Pharmacology, 2023
Introduction: Post-marketing identification and report of unknown adverse drug reactions (ADRs) are crucial for patient safety. However, complete information on unknown ADRs seldom is available at the time of spontaneous ADR reports and this can hamper ...
Francesca Filippi-Arriaga   +13 more
doaj   +1 more source

ADVERSE DRUG REACTION REPORTING PRACTICES BY HEALTH CARE PROFESSIONALS OF KARACHI, PAKISTAN: A QUALITATIVE SURVEY

open access: yesGomal Journal of Medical Sciences, 2021
Background: The safety of medications is of utmost concern for public health. In developed countries, adverse drug reaction reporting systems are well established, but in low-income and middle-income countries such as Pakistan, these are under-developed ...
Sidra Zaheer   +2 more
doaj   +1 more source

Pharmacovigilance as an imperative of modern medicine - experience from Montenegro [PDF]

open access: yesVojnosanitetski Pregled, 2017
nema
Mugoša Snežana   +5 more
doaj   +1 more source

Translation, transcultural adaptation and validation to Brazilian Portuguese of tools for adverse drug reaction assessment in children

open access: yesBMC Medical Research Methodology, 2021
Background Children are more vulnerable to adverse drug reactions (ADRs) due to complex changes in the body during the growth process and lack specific pharmacoepidemiologic studies.
Elisangela da Costa Lima   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy